Marty, C. et al. Germline JAK2 mutations in the kinase domain are responsible for hereditary thrombocytosis and are resistant to JAK2 and HSP90 inhibitors. Blood blood–2013–05–504555 (2014). doi:10.1182/blood-2013-05-504555
Marty, C. et al. Germline JAK2 mutations in the kinase domain are responsible for hereditary thrombocytosis and are resistant to JAK2 and HSP90 inhibitors. Blood blood–2013–05–504555 (2014). doi:10.1182/blood-2013-05-504555